Literature DB >> 21072540

Characterization of Leishmania spp. causing cutaneous leishmaniasis in Manaus, Amazonas, Brazil.

Leila Ines Camara Coelho1, Marcilene Paes, Jorge Augusto Guerra, Maria das Graças Barbosa, Candisse Coelho, Bruna Lima, Maria Edileuza Brito, Sinval Pinto Brandão Filho.   

Abstract

In the State of Amazonas, American tegumentary leishmaniasis is endemic and presents a wide spectrum of clinical variability due to the large diversity of circulating species in the region. Isolates from patients in Manaus and its metropolitan region were characterized using monoclonal antibodies and isoenzymes belonging to four species of the parasite: Leishmania (Viannia) guyanensis, 73% (153/209); Leishmania (Viannia) braziliensis, 14% (30/209); Leishmania (Leishmania) amazonensis, 8% (17/209); and Leishmania (Viannia) naiffii, 4% (9/209). The most prevalent species was L. (V.) guyanensis. The principal finding of this study was the important quantity of infections involving more than one parasite species, representing 14% (29/209) of the total. The findings obtained in this work regarding the parasite are further highlighted by the fact that these isolates were obtained from clinical samples collected from single lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21072540      PMCID: PMC3040821          DOI: 10.1007/s00436-010-2139-9

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


Introduction

Epidemiologically, American tegumentary leishmaniasis (ATL) is considered an enzootic disease aggravated by several factors. In the State of Amazonas, Brazil, four species of Leishmania are responsible for the disease in humans, involving clinical presentation in the cutaneous and mucosal forms: Leishmania (Viannia) guyanensis, Leishmania (Viannia) braziliensis, Leishmania (Viannia) naiffii, and Leishmania (Leishmania) amazonensis. In the last 12 years (1994 to 2005), an annual mean of 30,383 cases of tegumentary leishmaniasis have been registered. In 2006, 22,097 cases were notified and in 2007, 20,737 cases, which is an expressive decrease in the number of cases registered in previous years (http://www4.ensp.fiocruz.br/Leishmaniose/situacao-da-lt-no-brasil/). In the State of Amazonas, 12,005 cases were registered in the same period, with a mean incidence rate of 86.77; however, in 2003, the rate was 121.03, with 3,174 cases, 60.18% in the city of Manaus (Guerra et al. 2006). The cases are concentrated in the metropolitan region of Manaus, with around 600 cases per year, according to database of the Disease Notification Information System (Sistema de Informação de Agravos de Notificação, SINAN), run by the Secretary for Health and Safety (Secretaria de Vigilância em Saúde) of the Ministry of Health (http://dtr2004.saude.gov.br/sinanweb/tabnet/tabnet?sinan/lta/bases/ltabr.def). The classical taxonomic methods used for Leishmania classification and typing are based on a panel of specific monoclonal antibodies and an electrophoretic profile of isoenzymes (MLEE). Other methods based on DNA detection and sequencing are also used. Due to the abundance of the Amazon biodiversity, some authors have suggested that other species may exist in the region, including species not yet characterized that could also be responsible for infections in humans, given that flagellated forms of the parasite are frequently observed in mammals and phlebotomines in the region (Grimaldi et al. 1991; Silveira et al. 2004). The human cases of ATL in this region are mostly verified in the adult population who are involved in work related to agricultural activities, such as the extraction of rosewood oil and cassava cultivation, as well as other subsistence crops like beans and corn. The majority of the autochthonous cases are attended at the Manaus Tropical Medicine Institute Foundation (Fundação Instituto de Medicina Tropical de Manaus). Precise categorical identification of Leishmania spp. is fundamental to understanding the epidemiology of the disease and improving current knowledge concerning its pathology, the use of chemotherapy, and for implementing control measures. Specific monoclonal antibodies have been used for several years to identify Leishmania spp. (McMahon-Pratt et al. 1986; Grimaldi et al. 1987, 1991; Shaw and Lainson 1987, 1989; Barral-Neto et al. 1986; Barral 1988) and have demonstrated high and consistent specificity in the characterization of species of this parasite, unequivocally proving its identification (Grimaldi and Tesh 1993; Grimaldi and McMahon-Pratt 1996; Romero et al. 2002a, b, 2005; Abbas and Lichtman 2005). The electrophoretic mobility of enzymes (multilocus enzyme electrophoresis, MLEE) is another tool for categorically characterizing this parasite, revealing polymorphisms that express phenotypes of population variations and taxonomically classify the different species of Leishmania (Cupolillo et al. 1994, 1998; Saravia et al. 1998). In the last few years, polymerase chain reaction (PCR) has been widely used as a parasitological diagnostic test on clinical samples of patients with ATL, due to its high sensitivity (Barker et al. 1991; Degrave et al. 1994) and to detect natural infection in phlebotomine vectors and reservoir hosts (Pita-Pereira et al. 2005; Brandão-Filho and Shaw 2006). Its use has demonstrated greater sensitivity in relation to the conventional method of diagnosis based on direct parasitological exam under an optic microscope (Isaza et al. 1999; Rodrigues et al. 2002; Weigle et al. 2002). This study aimed to characterize the species of Leishmania isolated in patients with ATL originating from the city of Manaus and its metropolitan region, attended at the outpatient clinic of the Amazonas Tropical Medicine Foundation (Fundação de Medicina Tropical do Amazonas, FMTAM) in Manaus, relating patients’ location of origin to the species of parasite detected.

Material and methods

Patients

The individuals included in the study spontaneously sought attendance at the FMTAM, a reference center for tropical diseases in the State of Amazonas, Brazil, to obtain a clinical and laboratorial diagnosis of ATL. The patients all originated from the city of Manaus and municipalities of the metropolitan region: Itacoatiara, Manacapuru, Novo Airão, Rio Presidente Figueiredo, and Preto da Eva. The study was submitted to and approved by the Ethics in Research Committee of the FMTAM, under no. 1830/2006. All the participants signed a term of free and informed consent.

Parasitological exam

All the patients involved in the study were submitted to direct exam by scarification of the margins of a single typical lesion, followed by Giemsa staining, in accordance with Ministry of Health directives ( Brasil Ministério da Saúde and Fundação Nacional de Saúde 2000, 2002), to visualize the amastigotes under optic microscopy.

Isolation of Leishmania spp

Clinical samples obtained by fine needle aspiration biopsy of the margins of cutaneous lesions or fragments obtained by 3–4-mm punch biopsy, in accordance with the method described by Marzochi et al. (1993) and Romero et al. (2002a, b), were inoculated in Novy–Neal–Nicolle (NNN) culture medium, first described by Novy-Neal and Nicolle (1909) and modified by Shaw and Lainson (1981 and Shaw et al. (1989). The cultures were examined every 3 days for a maximum period of 30 days to detect promastigotes under optic microscopy.

Preparation of the parasitic mass for parasite characterization

The parasites were transferred from modified NNN culture medium to Schneider’s Drosophila medium (S9895, Sigma) containing 20% fetal bovine serum (FBS) and antibiotics (50 mg/ml of streptomycin and 100 U/ml of penicillin or 80 mg/ml of gentamicin). They were observed for 3 to 5 days until they achieved the stationary growth phase. Once this occurred, an aliquot of the culture was added to 4% formaldehyde diluted 1:1,000 in phosphate-buffered solution (PBS), followed by parasite counts in a Neubauer chamber at concentrations between 1 × 105 and 1 × 107. Next, they were washed twice in PBS, pH 7.2, and 0.01 M EDTA and centrifuged for 10 min at 2,500 rpm, in accordance with Evans et al. (1984; Evans 1989; Brasil Ministério da Saúde and Fundação Nacional de Saúde 2000). The parasite mass was separated into aliquots, which were frozen and stored at −20°C while awaiting characterization.

Analysis of monoclonal antibodies (serodemes)

Preparation of the parasites for monoclonal typing was performed in accordance with laboratorial protocol L30/181/4 of the WHO Special Program for Research and Training on Tropical Diseases (WHO/TDR, 2002). Indirect immunofluorescence reaction on monoclonal antibodies was performed using the following panel of 14 specific monoclonal antibodies: L. (V.) braziliensis (D3-complex), L. (V.) braziliensis (B12,16,18), L. (V.) guyanensis/panamensis (B19,4,5,7,11), L. (L.) amazonensis/venezuelensis (M3,7,8,P9), and L. (V.) naiffi (B1). Series D and B react with species of the subgenus Viannia and series M and P react with species of the subgenus Leishmania. The following international standard strains were used as positive controls: L. (V.) guyanensis (MHOM 4147), L. (V.) braziliensis (MHOM 2903), L. (L.) amazonensis (Ph8 and MHOM 81889), and L. (V.) naiffii (MHOM 5533).

Characterization by isoenzyme electrophoresis

Analysis of electrophoretic mobility using isoenzymes (MLEE) was performed using a system consisting of seven enzymes. Electrophoresis was performed on agarose gel and the allelic variations were tested for the following enzymes: isomerases: 6-phosphogluconate dehydrogenase (6PGDH, E.C.1.1.1.44), mannose phosphate isomerase (MPI, E.C.5.3.1.8), glucophosphate isomerase (GPI, E.C.5.3.1.9); transferases: phosphoglucomutase (PGM, E.C.2.7.5.1); oxidoreductases: glucose-6-phosphate dehydrogenase (G6PDH, E.C.1.1.1.49), isocitrate dehydrogenase (IDH-NADP, E.C.1.1.1.42); and lyases: aconitase (ACON, E.C.4.2.1.3). The method was performed in accordance with the conditions described by Cupolillo et al. (1994, 1998). Each isolate was compared to the WHO reference species mentioned above (WHO/TDR, 2002).

DNA detection by polymerase chain reaction (PCR)

DNA isolation was performed using the Genomic Prep Cells and Tissue DNA Isolation kit (Amershan Biociences), in accordance with the manufacturer’s recommendations. The PCR test for Leishmania (Viannia) spp. DNA was performed in accordance with De Bruijin and Barker (1992), using the kDNA minicircle region as the target and specific primers for the subgenus Viannia: B1-GGGGTTGGTGTAATATAGTGG 5′ to 3′ and B2-CTAATTGTGCACGGGGAGG 5′ to 3′. For the subgenus Leishmania (Leishmania) spp., the target was also the kDNA minicircle region and the primers were: RV1, (GC)(GC)(GC)CC(A/C)CTAT(A/T)TTACACCAACCCC 5′ to 3′ and RV2, GGGGAGGGGCGT 5′ to 3′, in accordance with Le Fichoux et al. (1999). The positive controls used were the same as the WHO reference strains used in the characterization by monoclonal antibodies and enzymes.

Results

A total of 209 Leishmania spp samples were isolated and characterized. The majority of the isolates, 61.2% (128/209), originated from patients who resided in Manaus, with 38.8% (81/209) residing in the metropolitan regions (Fig. 1). The direct parasitological exam by scarification was positive in 85.2% (178/209) of cases.
Fig. 1

Locations of case occurrence in Manaus and its metropolitan regions

Locations of case occurrence in Manaus and its metropolitan regions Men were predominant (77% (161/209)), and the mean patient age was 31.6 years old (Table 1).
Table 1

Distribution of ATL cases according to gender and age

Age groupMF
0–10119
11–206115
21–306926
31–404317
41–50385
51–60245
61–7052
>7123
Mean31.6310.25
Distribution of ATL cases according to gender and age Four parasite species were identified: L. (V.) guyanensis, 73.2% (153/209); L. (V.) braziliensis, 14.4% (30/209); L. (L.) amazonensis, 8.1% (17/209); and L. (V.) naiffii, 4.3% (9/209). However, of the total, 13.9% (29/209) of patients presented mixed infections: 4.8% (10/209) involving L. (V.) guyanensis and L. (V.) braziliensis; 4.8% (10/209) involving L. (V.) guyanensis and L. (V.) naiffi; 1.4% (3/209) involving L. (V.) guyanensis, L. (V.) braziliensis, and L. (V.) naiffi; 1.4% (3/209) involving L. (V.) guyanensis, L. (V.) braziliensis, and L. (L.) amazonensis; 0.5% (1/209) involving L. (V.) guyanensis and L. (L.) amazonensis; 0.5% (1/209) involving L. (V.) guyanensis, L. (V.) braziliensis, and L. (L.) amazonensis; 0.5% (1/209) involving L. (V.) guyanensis, L. (V.) naiffi, and L. (L.) amazonensis; and 0.5% (1/209) involving L. (V.) guyanensis, L. (V.) braziliensis, L. (V.) naiffi, and L. (L.) amazonensis (Table 2).
Table 2

Distribution of cases of mixed infections according to Leishmania spp. species

Parasite speciesNumber of casesPercentage
L. (V.) guyanensis e L. (V.) braziliensis 104.78
L. (V.) guyanensis e L. (V.) naiffi 104.78
L. (V.) guyanensis e L. (L.) amazonensis 10.48
L.(V.) guyanensis, L. (V.) braziliensis e L. (V.) naiffi 31.44
L. (V.) guyanensis, L. (V.) braziliensis e L. (L.) amazonensis 31.44
L. (V.) guyanensis, L. (V.) naiffi e L. (L.) amazonensis 10.48
L. (V.) guyanensis, L.(V.) braziliensis, L. (V.) naiffi e L. (L.) amazonensis 10.48
Distribution of cases of mixed infections according to Leishmania spp. species Characterization by MLEE revealed a greater frequency of alleles of 6PGDH (45.0%, 94/209), followed by PGM (24.9%, 52/209), G6PDH (23.0%, 48/209), GPI (21.5%, 45/209), ACON (19.1%, 40/209), IDH-NADP (16.7%, 35/209), and MPI (1.9%, 4/209). Quality control was achieved by randomly testing 15% of the isolates, performed by the reference laboratory for Leishmania typing and Leishmania spp. collection (CLIOC/FIOCRUZ), and the results were in agreement. Randomly selected samples from among the isolates characterized by monoclonal antibodies and MLEE (32.5%; 68/209) were submitted to the PCR test. Among these, 21.5% (45/209) were positive for the subgenus Viannia target and 11.0% (23/209) for the subgenus Leishmania. The mean time of disease evolution was 33 days. No significant differences were observed among the patients who were identified with mixed infections compared to the disease evolution time in the remaining patients infected by a single species. The only patient typed as a carrier of four Leishmania spp. species was a male, 36 years of age, and a farmer, who presented five typical lesions on one leg, one hand, and on both arms.

Discussion

American tegumentary leishmaniasis is endemic in the State of Amazonas, where it presents a wide spectrum of clinical variability due to the diversity of species circulating in the region. The most prevalent species is L. (V.) guyanensis, showing greatest concentration in the area of the city of Manaus and the surrounding metropolitan region. The findings obtained in this study regarding the parasite are in agreement with those obtained by (Naiff 1998) and Romero et al. (2000, 2001a, 2002a, 2005). The most relevant finding of this work was the high percentage of patients who presented mixed infections, particularly when considering that the isolates were obtained from clinical samples taken from a single lesion. This further corroborates the reports of other researchers, including Shaw (1985), Shaw and Lainson (1987), Shaw et al. (1989), Grimaldi and McMahon-Pratt (1996), Strelkova et al. (1990a, b, 1997), Saravia et al. (1998), Vray (1998), Bastrenta et al. (2003), and Brito et al. (2009), which were conducted in several regions in Brazil and in other countries. It should be noted that the findings reported by Shaw (1985) were obtained from clinical samples collected from more than one lesion per patient. These data also elucidate the diversity and heterogeneity of the disease and the complexity of the transmission cycles in this region in relation to the phlebotomines and reservoir hosts involved. The heterogeneity observed in mixed infections involving L. (V.) guyanensis, L. (V.) braziliensis, L. (V.) naiffii, and L. (L.) amazonensis and their capacity for concomitant survival while causing ATL, contrasts with the homogeneity of parasites isolated in other regions, particularly in the northeast and southeast of Brazil (Brito et al. 1993; Brandão-Filho et al. 2003; Cupolillo et al. 2003). Brito et al. (2009) verified 10 different zymodemes in isolates of L. (V.) braziliensis and Leishmania (Viannia) shawii, originating from the Atlantic Forest zone in Pernambuco, northeastern Brazil, confirming the coexistence of two species that divided the same ecosystem and interfered in the natural genetic polymorphism of the Leishmania spp. populations in this endemic region. The results of typing using monoclonal antibodies were consistent with characterization by MLEE. Cases of cutaneous leishmaniasis can achieve cure spontaneously; however, in this study, all the patients were treated. Since disease notification is compulsory, all the cases were registered in the SINAN. Mixed infections have been reported in other diseases caused by different protozoans. In cases of malaria, up to 27.0% (Lorenzetti et al. 2008) of mixed infections have been verified in certain areas, demonstrating the coexistence of two species (Plasmodium falciparum and Plasmodium vivax) which contributes to increased virulence, transmissibility, and resistance to drugs due to intrahost competition (Havyliuk and Ferreira, 2009). Characterization of the origin of the isolates provided detailed information regarding the distribution of the diversity of circulating species in Manaus, including the predominance of L. (V.) guyanensis. The municipalities of the metropolitan area that form AM010 (Rio Preto da Eva and Itacoatiara) presented a greater frequency of L. (V.) braziliensis and this species in association with other species. Although all the patients responded to treatment, even when successful, cutaneous leishmaniasis can still relapse or even evolve to the mucosal form. According to both Schubach et al. (1988) and Mendonça et al. (2004), the parasite can remain latent, so continuous follow-up is necessary in these patients. Romero et al. (2001a, b) observed a casuistic of clinical characteristics in patients with ATL associated with L. (V.) guyanensis and correlated lesion size and numbers, which presented a larger number of lesions with smaller diameters than those who were infected by L. (V.) braziliensis. Multiple lesions can be explained by the occurrence of simultaneous bites by several infected insects and/or metastasis by hematogenic route (Naiff et al. 1999). Similar observations were made in this work, in agreement with Naiff et al. (1999), such that in patients presenting mixed infection, variations in lesion size and numbers also occurred. Campbell-Lendrum et al. (2001) observed a change in the epidemiological pattern of leishmaniases transmission in several South American countries, with important domiciliation of the vectors in Venezuela, Peru, Bolivia, and Brazil. Analysis of these data demonstrates that disappearance of the disease in South America is not likely to occur, since domiciliation of the vector had already established and was currently evident in various Brazilian regions (Brandão-Filho et al. 1999). The vectors Lutzomyia umbratilis and Lutzomyia anduzei are considered the principal and second most important transmitters in this region of Manaus, respectively (Guerra et al. 2006), while in a casuistic of 65 patients, Naiff et al. (1999) determined that 91% presented cutaneous lesions exclusively caused by L. (V.) guyanensis. They also verified an increase in the occurrence of cases in the rainy season (May–October) due to the high vector population density. Further studies are required to confirm whether a tendency for urbanization exists in the expansion of the disease and in relation to the findings regarding mixed infections verified in this work. Characterizing the current status of the phlebotomine fauna and reservoir hosts responsible for the maintenance of the zoonotic cycle of American tegumentary leishmaniasis in the region is fundamental in order to assist in the adoption of measures directed at the surveillance and control of this important endemic disease in the State of Amazonas.
  44 in total

1.  Identification of antigenically distinct populations of Leishmania (Viannia) guyanensis from Manaus, Brazil, using monoclonal antibodies.

Authors:  Gustavo Adolfo Sierra Romero; Edna Ishikawa; Elisa Cupolillo; Cristiane Bentin Toaldo; Marcus Vinitius de Farias Guerra; Marcilene Gomes Paes; Vanize de Oliveira Macêdo; Jeffrey J Shaw
Journal:  Acta Trop       Date:  2002-04       Impact factor: 3.112

2.  Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil.

Authors:  Elisa Cupolillo; Lúcia Regina Brahim; Cristiane B Toaldo; Manoel Paes de Oliveira-Neto; Maria Edileuza Felinto de Brito; Aloisio Falqueto; Maricleide de Farias Naiff; Gabriel Grimaldi
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

3.  PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia).

Authors:  Kristen A Weigle; Luz Angela Labrada; Caterin Lozano; Cecilia Santrich; Douglas C Barker
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach.

Authors:  G A Romero; M Vinitius De Farias Guerra; M Gomes Paes; V de Oliveira Macêdo
Journal:  Clin Infect Dis       Date:  2001-04-13       Impact factor: 9.079

5.  Sensitivity of the polymerase chain reaction for the diagnosis of cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis.

Authors:  G A Romero; M V Guerra; M G Paes; E Cupolillo; C Bentin Toaldo; V O Macêdo; O Fernandes
Journal:  Acta Trop       Date:  2001-06-22       Impact factor: 3.112

6.  Epidemiological surveys confirm an increasing burden of cutaneous leishmaniasis in north-east Brazil.

Authors:  S P Brandão-Filho; D Campbell-Lendrum; M E Brito; J J Shaw; C R Davies
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Sep-Oct       Impact factor: 2.184

7.  Species diversity of Leishmania (Viannia) parasites circulating in an endemic area for cutaneous leishmaniasis located in the Atlantic rainforest region of northeastern Brazil.

Authors:  Maria Edileuza F Brito; Maria S Andrade; Mitzi G Mendonça; Cláudio J Silva; Ericka L Almeida; Bruna S Lima; Simone M Félix; Frederico G C Abath; Grazielle C da Graça; Renato Porrozzi; Edna A Ishikawa; Jeffrey J Shaw; Elisa Cupolillo; Sinval P Brandão-Filho
Journal:  Trop Med Int Health       Date:  2009-08-25       Impact factor: 2.622

8.  Human mixed infections of Leishmania spp. and Leishmania-Trypanosoma cruzi in a sub Andean Bolivian area: identification by polymerase chain reaction/hybridization and isoenzyme.

Authors:  B Bastrenta; N Mita; R Buitrago; F Vargas; M Flores; M Machane; N Yacsik; M Torrez; F Le Pont; F Brenière
Journal:  Mem Inst Oswaldo Cruz       Date:  2003-05-15       Impact factor: 2.743

9.  Evaluation of PCR for diagnosis of American cutaneous leishmaniasis in an area of endemicity in northeastern Brazil.

Authors:  Eduardo Henrique Gomes Rodrigues; Maria Edileuza Felinto de Brito; Mitzi Guedes Mendonça; Roberto P Werkhäuser; Eridan M Coutinho; Wayner V Souza; Maria de Fátima P Militão de Albuquerque; Márcio L Jardim; Frederico G C Abath
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

10.  The rarity of infection with Leishmania (Viannia) braziliensis among patients from the Manaus region of Amazonas state, Brazil, who have cutaneous leishmaniasis.

Authors:  G A S Romero; E Ishikawa; E Cupolillo; C B Toaldo; M V F Guerra; M G Paes; V O Macêdo; J J Shaw
Journal:  Ann Trop Med Parasitol       Date:  2002-03
View more
  21 in total

1.  Comparative genomics of canine-isolated Leishmania (Leishmania) amazonensis from an endemic focus of visceral leishmaniasis in Governador Valadares, southeastern Brazil.

Authors:  Hugo O Valdivia; Laila V Almeida; Bruno M Roatt; João Luís Reis-Cunha; Agnes Antônia Sampaio Pereira; Celia Gontijo; Ricardo Toshio Fujiwara; Alexandre B Reis; Mandy J Sanders; James A Cotton; Daniella C Bartholomeu
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

2.  Leishmania sp. identification by PCR associated with sequencing of target SSU rDNA in paraffin-embedded skin samples stored for more than 30 years.

Authors:  Ana Carolina S de Lima; Ricardo A Zampieri; Thaíse Y Tomokane; Márcia D Laurenti; Fernando T Silveira; Carlos E P Corbett; Lucile M Floeter-Winter; Cláudia M C Gomes
Journal:  Parasitol Res       Date:  2010-12-15       Impact factor: 2.289

3.  American tegumentary leishmaniasis and HIV-AIDS association in a tertiary care center in the Brazilian Amazon.

Authors:  Jorge Augusto O Guerra; Leíla I R C Coelho; Flávio R Pereira; André M Siqueira; Rogério L Ribeiro; Thiago Miranda L Almeida; Marcus Vinícius G Lacerda; Maria das Graças V Barbosa; Sinésio Talhari
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

4.  An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.

Authors:  Letícia Martins Dos Reis Lage; José Mário Barichello; Daniela Pagliara Lage; Débora Vasconcelos Costa Mendonça; Ana Maria Ravena Severino Carvalho; Marcella Rezende Rodrigues; Daniel Menezes-Souza; Bruno Mendes Roatt; Ricardo José Alves; Carlos Alberto Pereira Tavares; Eduardo Antonio Ferraz Coelho; Mariana Costa Duarte
Journal:  Parasitol Res       Date:  2016-07-01       Impact factor: 2.289

5.  Ecological aspects and molecular detection of Leishmania DNA Ross (Kinetoplastida: Trypanosomatidae) in phlebotomine sandflies (Diptera: Psychodidae) in terra firme and várzea environments in the Middle Solimões Region, Amazonas State, Brazil.

Authors:  Antonio Marques Pereira Júnior; Carolina Bioni Garcia Teles; Ana Paula de Azevedo dos Santos; Moreno de Souza Rodrigues; Eric Fabrício Marialva; Felipe Arley Costa Pessoa; Jansen Fernandes Medeiros
Journal:  Parasit Vectors       Date:  2015-03-25       Impact factor: 3.876

6.  Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients.

Authors:  Lilian Motta Cantanhêde; Cipriano Ferreira da Silva Júnior; Marcos Massayuki Ito; Kátia Paula Felipin; Roberto Nicolete; Juan Miguel Villalobos Salcedo; Renato Porrozzi; Elisa Cupolillo; Ricardo de Godoi Mattos Ferreira
Journal:  PLoS Negl Trop Dis       Date:  2015-09-15

7.  Population structure and evidence for both clonality and recombination among Brazilian strains of the subgenus Leishmania (Viannia).

Authors:  Katrin Kuhls; Elisa Cupolillo; Soraia O Silva; Carola Schweynoch; Mariana Côrtes Boité; Maria N Mello; Isabel Mauricio; Michael Miles; Thierry Wirth; Gabriele Schönian
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31

8.  The genome sequence of Leishmania (Leishmania) amazonensis: functional annotation and extended analysis of gene models.

Authors:  Fernando Real; Ramon Oliveira Vidal; Marcelo Falsarella Carazzolle; Jorge Maurício Costa Mondego; Gustavo Gilson Lacerda Costa; Roberto Hirochi Herai; Martin Würtele; Lucas Miguel de Carvalho; Renata Carmona e Ferreira; Renato Arruda Mortara; Clara Lucia Barbiéri; Piotr Mieczkowski; José Franco da Silveira; Marcelo Ribeiro da Silva Briones; Gonçalo Amarante Guimarães Pereira; Diana Bahia
Journal:  DNA Res       Date:  2013-07-15       Impact factor: 4.458

9.  An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis.

Authors:  Tatiana G Ribeiro; Juçara R Franca; Leonardo L Fuscaldi; Mara L Santos; Mariana C Duarte; Paula S Lage; Vivian T Martins; Lourena E Costa; Simone O A Fernandes; Valbert N Cardoso; Rachel O Castilho; Manuel Soto; Carlos A P Tavares; André A G Faraco; Eduardo A F Coelho; Miguel A Chávez-Fumagalli
Journal:  Int J Nanomedicine       Date:  2014-11-19

10.  Applicability of kDNA-PCR for routine diagnosis of American tegumentary leishmaniasis in a tertiary reference hospital.

Authors:  Marcela M Satow; Edite H Yamashiro-Kanashiro; Mussya C Rocha; Luiza K Oyafuso; Rita C Soler; Paulo C Cotrim; José Angelo L Lindoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Nov-Dec       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.